Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study device became unavailable for use.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Women suffering from stress urinary incontinence are offered pelvic floor physiotherapy as an optional treatment. Strengthening of the pelvic floor is measured to date by manual examination and lacks precise evaluation. The vaginal tactile imager assists in evaluation of the changes in the pelvic floor after physiotherapy.
Women with stress urinary incontinence will undergo 6-10 pelvic floor strengthening physiotherapy sessions. The participants will undergo a short examination of vaginal elasticity using a vaginal tactile imager prior to beginning physiotherapy and additional examinations after 6 treatments, 10 treatments and 3 and 6 months post-treatment cessation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stress urinary incontinence | Women suffering from stress urinary incontinence |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vaginal tactile imager | Diagnostic Test | Vaginal elasticity evaluation using a vaginal tactile imager |
|
| Measure | Description | Time Frame |
|---|---|---|
| Vaginal Elasticity | Changes in vaginal elasticity post physiotherapy | From the treatment cessation up to 6 months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Stress urinary incontinence | Improvement in the urogenital distress inventory questionnaire score (range 0-15) | From the treatment cessation up to 6 months post-treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Female
Women between 18-70 years of age, suffering from stress urinary incontinence, referred to pelvic floor physiotherapy.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Roy Lauterbach, MD | Rambam Health Care Campus | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |